Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
CrossRef Assessing Activity Limitation Among Cancer Survivors in Korea Using Data from a Nationwide Survey Myueng Guen Oh, Mi Ah Han, Yu Mi Byeon, Kyung Min Bae, Seong-Hyung Choi Asian Pacific Journal of Cancer Prevention.2015
This article provides a factual comparison of BPC-157 and TB-500 across their structure, mechanisms, published research, and why they are often studied together
FDA approval of Foundayo, the only approved GLP-1 pill that can be taken any time of day, without food and water restrictions. An oral GLP-1 dramatically expands the addressable obesity market beyond injectables
High prices of medicines like semaglutide and tirzepatide are limiting access to these medicines, the WHO has stated
US$ 21.90
US$ 21.95
US$ 29.62
US$ 26.51
US$ 25.73
US$ 21.72
US$ 28.23
US$ 29.97
US$ 20.80
US$ 21.73
US$ 27.31
US$ 27.16
US$ 28.47
